2-mercaptomethyl-3-guanidinoethylthiopropionic acid has been researched along with Blood Pressure, High in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bispo-da-Silva, LB; Oliveira, EB; Resende, AC; Salgado, MC; Sivieri, DO | 1 |
1 other study(ies) available for 2-mercaptomethyl-3-guanidinoethylthiopropionic acid and Blood Pressure, High
| Article | Year |
|---|---|
Potentiation of bradykinin effect by angiotensin-converting enzyme inhibition does not correlate with angiotensin-converting enzyme activity in the rat mesenteric arteries.
Topics: 3-Mercaptopropionic Acid; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Bradykinin; Drug Synergism; Enzyme Inhibitors; Glycopeptides; Hypertension; In Vitro Techniques; Lysine Carboxypeptidase; Male; Mesenteric Arteries; Metalloendopeptidases; Neprilysin; Peptide Fragments; Peptidyl-Dipeptidase A; Protease Inhibitors; Rats; Rats, Wistar; Vasodilation; Vasodilator Agents | 2007 |